Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05422911
Title Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors James J. Peters Veterans Affairs Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.